A phase 1 study of HIEstem.
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs Mesenchymal Stem Cell therapy Medinno (Primary)
- Indications Brain hypoxia-ischaemia
- Focus Adverse reactions
- 15 Jan 2025 New trial record
- 19 Dec 2024 According to Medino 's Media Release, Histem completed phase 1 clinical administration at the end of last year and completed short-term follow-up observations for the last patient this year.